In addition, studies state that this hypothesis is supported by the expression of M-CSF, which stimulates the myeloid series, and RANKL/RANK, which contributes to bone remodeling in cancer progression, especially in breast cancer. This evidence concerns the gene TNFRSF11A and cancer.